Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Zisen Lai"'
Autor:
Youshi Zheng, Zisen Lai, Bing Wang, Zuwu Wei, Yongyi Zeng, Qiuyu Zhuang, Xiaolong Liu, Kecan Lin
Publikováno v:
Discover Oncology, Vol 14, Iss 1, Pp 1-14 (2023)
Abstract Introduction Natural killer cells can attack cancer cells without prior sensitization, but their clinical benefit is limited owing to their poor selectivity that is caused by the lack of specific receptors to target tumor cells. In this stud
Externí odkaz:
https://doaj.org/article/02e35f0973d44a0a85c7f53cb55670af
Autor:
Jun Fu, Qinjunjie Chen, Zisen Lai, Kongying Lin, Guoxu Fang, Zongren Ding, Yuzhen Gao, Yongyi Zeng
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-15 (2023)
Abstract Background Inflammation is implicated in tumorigenesis and has been reported as an important prognostic factor in cancers. In this study, we aimed to develop and validate a novel inflammation score (IFS) system based on 12 inflammatory marke
Externí odkaz:
https://doaj.org/article/96a43fb73b804589999a340c9c7766cf
Autor:
Kongying Lin, Fuqun Wei, Qizhen Huang, Zisen Lai, Jinyu Zhang, Qingjing Chen, Yabin Jiang, Jie Kong, Shichuan Tang, Jianhuai Lin, Yufeng Chen, Jinhong Chen, Yongyi Zeng
Publikováno v:
Journal of Hepatocellular Carcinoma. 9:127-140
Kongying Lin,1,* Fuqun Wei,1,2,* Qizhen Huang,3,* Zisen Lai,1,* Jinyu Zhang,1 Qingjing Chen,1 Yabin Jiang,1 Jie Kong,1,4 Shichuan Tang,1 Jianhuai Lin,5 Yufeng Chen,6 Jinhong Chen,7 Yongyi Zeng1,8 1Department of Hepatopancreatobiliary
Autor:
Jun Fu, Qinjunjie Chen, Zisen Lai, Kongying Lin, Guoxu Fang, Zongren Ding, Yuzhen Gao, Yongyi Zeng
Background Inflammation is implicated in tumorigenesis and has been reported as an important prognostic factor in cancers. In this study, we aimed to develop and validate a novel inflammation score (IFS) system based on 12 inflammatory markers and ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7af95a88898d657715b5251cf7160abf
https://doi.org/10.21203/rs.3.rs-1161886/v1
https://doi.org/10.21203/rs.3.rs-1161886/v1
Publikováno v:
Nanoscale. 13(25)
Modulating interactions between immune effector cells and tumor cells in vivo using a bispecific aptamer (Ap) is a promising strategy for cancer immunotherapy. However, it remains a technical challenge owing to the complex and dynamic internal enviro